Inhalation Spray Label Revised to Include New Data, Broader Indication
October 12th 2018The FDA has approved new labeling for Boehringer Ingelheim's Stiolto Respimat (tiotropium bromide & olodaterol) Inhalation Spray that includes data showing a meaningful reduction in COPD exacerbations driven by tiotropium.
Read More